Document:

Amended and Restated 2000 Long-Term Incentive Plan

 Exhibit (xxxvi) 
  
 NDCHEALTH CORPORATION 
 AMENDED AND RESTATED 2000 LONG-TERM INCENTIVE PLAN 
  
 ARTICLE 1 
 PURPOSE 
  
 1.1 GENERAL. The purpose of the NDCHealth Corporation Amended and Restated 2000 Long-Term Incentive Plan (the
“Plan”) is to promote the success, and enhance the value, of NDCHealth Corporation (the “Company”), by linking the personal interests of its employees, officers and directors to those of Company stockholders and by providing its
employees, officers and directors with an incentive for outstanding performance. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of employees, officers and directors
upon whose judgment, interest, and special effort the successful conduct of the Company’s operation is largely dependent. Accordingly, the Plan permits the grant of incentive awards from time to time to selected employees, officers, and
directors. 
  
 ARTICLE 2 
 EFFECTIVE DATE 
  
 2.1 EFFECTIVE DATE. The Plan shall be effective as of the date upon which it shall be approved by the stockholders of the Company (the “Effective
Date”). 
  
 ARTICLE 3 
 DEFINITIONS 
  
 3.1 DEFINITIONS. When a word or phrase appears in this Plan with the initial letter capitalized, and the word or phrase does not commence a sentence, the
word or phrase shall generally be given the meaning ascribed to it in this Section or in Section 1.1 unless a clearly different meaning is required by the context. The following words and phrases shall have the following meanings: 
  
 (a) “Award” means any Option, Stock Appreciation
Right, Restricted Stock Award, Performance Share Award, Dividend Equivalent Award, or Other Stock-Based Award, or any other right or interest relating to Stock or cash, granted to a Participant under the Plan. 
  
 (b) “Award Agreement” means any written agreement,
contract, or other instrument or document evidencing an Award. 
  
 (c) “Board” means the Board of Directors of the Company. 
  
 (e) “Code” means the Internal Revenue Code of 1986, as amended from time to time. 

 (f) “Committee” means the committee of the Board described in Article 4.

  
 (g) “Company” means NDCHealth
Corporation, a Delaware corporation, formerly named National Data Corporation. 
  
 (h) “Covered Employee” means a covered employee as defined in Code Section 162(m)(3). 
  
 (i) “Disability” shall mean any illness or other
physical or mental condition of a Participant that renders the Participant incapable of performing his customary and usual duties for the Company, or any medically determinable illness or other physical or mental condition resulting from a bodily
injury, disease or mental disorder which, in the judgment of the Committee, is permanent and continuous in nature. The Committee may require such medical or other evidence as it deems necessary to judge the nature and permanency of the
Participant’s condition. Notwithstanding the above, with respect to an Incentive Stock Option, Disability shall mean Permanent and Total Disability as defined in Section 22(e)(3) of the Code. 
  
 (j) “Dividend Equivalent” means a right granted to
a Participant under Article 11. 
  
 (k)
“Effective Date” has the meaning assigned such term in Section 2.1. 
  
 (l) “Fair Market Value”, on any date, means (i) if the Stock is listed on a securities exchange or is traded over the Nasdaq National Market, the closing sales price on such exchange or over such system on
such date or, in the absence of reported sales on such date, the closing sales price on the immediately preceding date on which sales were reported, or (ii) if the Stock is not listed on a securities exchange or traded over the Nasdaq National
Market, the mean between the bid and offered prices as quoted by Nasdaq for such date, provided that if it is determined that the fair market value is not properly reflected by such Nasdaq quotations, Fair Market Value will be determined by such
other method as the Committee determines in good faith to be reasonable. 
  
 (m) “Incentive Stock Option” means an Option that is intended to meet the requirements of Section 422 of the Code or any successor provision thereto. 
  
 (n) “Non-Qualified Stock Option” means an Option
that is not an Incentive Stock Option. 
  

 2 

 (o) “Option” means a right granted to a Participant under Article 7 of the Plan
to purchase Stock at a specified price during specified time periods. An Option may be either an Incentive Stock Option or a Non-Qualified Stock Option. 
  
 (p) “Other Stock-Based Award” means a right, granted to a Participant under Article 12, that relates to or is valued by
reference to Stock or other Awards relating to Stock. 
  
 (q) “Parent” means a corporation which owns or beneficially owns a majority of the outstanding voting stock or voting power of the Company. For Incentive Stock Options, the term shall have the same meaning as set forth in Code
Section 424(e). 
  
 (r) “Participant”
means a person who, as an employee, officer or director of the Company or any Parent or Subsidiary, has been granted an Award under the Plan. 
  
 (s) “Performance Share” means a right granted to a Participant under Article 9, to receive cash, Stock, or other Awards, the
payment of which is contingent upon achieving certain performance goals established by the Committee. 
  
 (t) “Plan” means the NDCHealth Corporation Amended and Restated 2000 Long-Term Incentive Plan, as amended from time to time.

  
 (u) “Restricted Stock Award” means
Stock granted to a Participant under Article 10 that is subject to certain restrictions and to risk of forfeiture. 
  
 (v) “Retirement” in the case of an employee means termination of employment with the Company, a Parent or Subsidiary after
attaining a total combination of age and years of service of at least 70; provided, however, that a termination of employment prior to age 60 shall not constitute Retirement for purposes of the Plan unless the Participant shall have given 12 months
advance written notice to the Company of his or her intent to retire, or the Company shall have expressly waived such prior notice. “Retirement” in the case of a non-employee director of the Company means retirement of the director in
accordance with the provisions of the Company’s bylaws as in effect from time to time or the failure to be re-elected or re-nominated as a director. 
  
 (w) “Stock” means the $.125 par value common stock of the Company and such other securities of the Company as may be substituted
for Stock pursuant to Article 14. 
  
 (x)
“Stock Appreciation Right” or “SAR” means a right granted to a Participant under Article 8 to receive a payment equal to the difference between the Fair Market Value of a share of Stock as of the date of exercise of the SAR over
the grant price of the SAR, all as determined pursuant to Article 8. 
  

 3 

 (y) “Subsidiary” means any corporation, limited liability company, partnership
or other entity of which a majority of the outstanding voting stock or voting power is beneficially owned directly or indirectly by the Company. For Incentive Stock Options, the term shall have the meaning set forth in Code Section 424(f).

  
 (z) “1933 Act” means the Securities
Act of 1933, as amended from time to time. 
  
 (aa) “1934 Act” means the Securities Exchange Act of 1934, as amended from time to time. 
  
 ARTICLE 4 
 ADMINISTRATION 
  
 4.1 COMMITTEE. The Plan shall be administered by a committee (the
“Committee”) appointed by the Board (which Committee shall consist of two or more directors) or, at the discretion of the Board from time to time, the Plan may be administered by the Board. It is intended that the directors appointed to
serve on the Committee shall be “non-employee directors” (within the meaning of Rule 16b-3 promulgated under the 1934 Act) and “outside directors” (within the meaning of Code Section 162(m) and the regulations thereunder).
However, the mere fact that a Committee member shall fail to qualify under either of the foregoing requirements shall not invalidate any Award made by the Committee which Award is otherwise validly made under the Plan. The members of the Committee
shall be appointed by, and may be changed at any time and from time to time in the discretion of, the Board. During any time that the Board is acting as administrator of the Plan, it shall have all the powers of the Committee hereunder, and any
reference herein to the Committee (other than in this Section 4.1) shall include the Board. 
  
 4.2 ACTION BY THE COMMITTEE. For purposes of administering the Plan, the following rules of procedure shall govern the Committee. A majority of the Committee shall constitute a quorum. The acts of a majority of the
members present at any meeting at which a quorum is present, and acts approved unanimously in writing by the members of the Committee in lieu of a meeting, shall be deemed the acts of the Committee. Each member of the Committee is entitled to, in
good faith, rely or act upon any report or other information furnished to that member by any officer or other employee of the Company or any Parent or Subsidiary, the Company’s independent certified public accountants, or any executive
compensation consultant or other professional retained by the Company to assist in the administration of the Plan. No member of the Committee shall be liable for any action or determination made in good faith, and members of the Committee shall be
entitled to indemnification and reimbursement from time to time for expenses incurred in defense of such good faith action or determination. 
  

 4 

 4.3 AUTHORITY OF COMMITTEE. The Committee has the exclusive power, authority and discretion to:

  
 (a) Designate Participants; 
  
 (b) Determine the type or types of Awards to be granted to
each Participant; 
  
 (c) Determine the number of
Awards to be granted and the number of shares of Stock to which an Award will relate; 
  
 (d) Determine the terms and conditions of any Award granted under the Plan, including but not limited to, the exercise price, grant price,
or purchase price, any restrictions or limitations on the Award, any schedule for lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations or waivers thereof, based in each case on such considerations as
the Committee in its sole discretion determines; 
  
 (e) Accelerate the vesting or lapse of restrictions of any outstanding Award, based in each case on such considerations as the Committee in its sole discretion determines; 
  
 (f) Determine whether, to what extent, and under what circumstances an Award may be settled in, or the
exercise price of an Award may be paid in, cash, Stock, other Awards, or other property, or an Award may be canceled, forfeited, or surrendered; 
  
 (g) Prescribe the form of each Award Agreement, which need not be identical for each Participant; 
  
 (h) Decide all other matters that must be determined in
connection with an Award; 
  
 (i) Establish,
adopt or revise any rules and regulations as it may deem necessary or advisable to administer the Plan; 
  
 (j) Make all other decisions and determinations that may be required under the Plan or as the Committee deems necessary or advisable to
administer the Plan; and 
  
 (k) Amend the Plan
or any Award Agreement as provided herein. 
  

 5 

 4.4. DECISIONS BINDING. The Committee’s interpretation of the Plan, any Awards granted under the
Plan, any Award Agreement and all decisions and determinations by the Committee with respect to the Plan are final, binding, and conclusive on all parties. 
  
 ARTICLE 5 
 SHARES SUBJECT TO THE PLAN

  
 5.1. NUMBER OF SHARES. Subject to adjustment as provided
in Section 14.1, the aggregate number of shares of Stock reserved and available for Awards or which may be used to provide a basis of measurement for or to determine the value of an Award, such as with a SAR or Performance Share Award,
(“Available Shares”) shall be 1,000,000 shares, plus an annual increase to be added on the last day of the Company’s fiscal year in each year, beginning in 2000 and ending in 2004, equal to the lesser of (i) 2,500,000 shares or (ii)
the number of shares necessary to bring the total number of Available Shares to 3.5% of the fully diluted shares outstanding on such date. Not more than 15% of the total authorized shares may be granted as Awards of Restricted Stock or unrestricted
Stock Awards. 
  
 5.2. LAPSED AWARDS. To the extent that an Award
is canceled, terminates, expires or lapses for any reason, any shares of Stock subject to the Award will again be available for the grant of an Award under the Plan and shares subject to SARs or other Awards settled in cash will be available for the
grant of an Award under the Plan. 
  
 5.3. STOCK DISTRIBUTED. Any
Stock distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Stock, treasury Stock or Stock purchased on the open market. 
  

5.4. LIMITATION ON AWARDS. Notwithstanding any provision in the Plan to the contrary (but subject to adjustment as provided in Section 14.1), the
maximum number of shares of Stock with respect to one or more Options and/or SARs that may be granted during any one calendar year under the Plan to any one Participant shall be 500,000. The maximum fair market value (measured as of the date of
grant) of any Awards other than Options and SARs that may be received by any one Participant (less any consideration paid by the Participant for such Award) during any one calendar year under the Plan shall be $5,000,000. 
  
 ARTICLE 6 
 ELIGIBILITY 
  
 6.1. GENERAL. Awards may be granted only to individuals who are employees, officers or directors of the Company or a Parent or Subsidiary. 
  

 6 

 ARTICLE 7 
 STOCK OPTIONS 
  
 7.1.
GENERAL. The Committee is authorized to grant Options to Participants on the following terms and conditions: 
  
 (a) EXERCISE PRICE. The exercise price per share of Stock under an Option shall be determined by the Committee. 
  
 (b) TIME AND CONDITIONS OF EXERCISE. The Committee shall
determine the time or times at which an Option may be exercised in whole or in part. The Committee also shall determine the performance or other conditions, if any, that must be satisfied before all or part of an Option may be exercised. The
Committee may waive any exercise provisions at any time in whole or in part based upon factors as the Committee may determine in its sole discretion so that the Option becomes exerciseable at an earlier date. 
  
 (c) PAYMENT. The Committee shall determine the methods by
which the exercise price of an Option may be paid, the form of payment, including, without limitation, cash, shares of Stock, or other property (including “cashless exercise” arrangements), and the methods by which shares of Stock shall be
delivered or deemed to be delivered to Participants; provided, however, that if shares of Stock are used to pay the exercise price of an Option, such shares must have been held by the Participant for at least six months. 
  
 (d) EVIDENCE OF GRANT. All Options shall be evidenced by a
written Award Agreement between the Company and the Participant. The Award Agreement shall include such provisions, not inconsistent with the Plan, as may be specified by the Committee. 
  
 7.2. INCENTIVE STOCK OPTIONS. The terms of any Incentive Stock Options granted under the Plan must comply with the following
additional rules: 
  
 (a) EXERCISE PRICE. The
exercise price per share of Stock shall be set by the Committee, provided that the exercise price for any Incentive Stock Option shall not be less than the Fair Market Value as of the date of the grant. 
  
 (b) EXERCISE. In no event may any Incentive Stock Option be
exercisable for more than ten years from the date of its grant. 
  
 (c) LAPSE OF OPTION. An Incentive Stock Option shall lapse under the earliest of the following circumstances; provided, however, that the Committee may, prior to the lapse of the Incentive Stock Option under the
circumstances described in paragraphs (3), (4) and (5) below, provide in writing that the Incentive Stock Option will extend until a later date, but if an Incentive 

  

 7 

 
Stock Option is exercised after the dates specified in paragraphs (3), (4) and (5) below, it will automatically become a Non-Qualified Stock Option:

  
 (1) The Incentive Stock Option shall lapse as
of the option expiration date set forth in the Award Agreement. 
  
 (2) The Incentive Stock Option shall lapse ten years after it is granted, unless an earlier time is set in the Award Agreement. 
  

(3) If the Participant terminates employment for any reason other than as provided in paragraph (4) or (5) below, the Incentive Stock
Option shall lapse, unless it is previously exercised, three months after the Participant’s termination of employment. 
  
 (4) If the Participant terminates employment by reason of his Disability, the Incentive Stock Option shall lapse, unless it is previously
exercised, one year after the Participant’s termination of employment. 
  
 (5) If the Participant dies while employed, or during the three-month period described in paragraph (3) or during the one-year period described in paragraph (4) and before the Option otherwise lapses, the Incentive
Stock Option shall lapse one year after the Participant’s death. Upon the Participant’s death, any exercisable Incentive Stock Options may be exercised by the Participant’s beneficiary, determined in accordance with Section 13.6.

  
 Unless the exercisability of the Incentive
Stock Option is accelerated as provided in Article 13, if a Participant exercises an Incentive Stock Option after termination of employment, the Incentive Stock Option may be exercised only with respect to the shares that were otherwise vested on
the Participant’s termination of employment. 
  
 (d) INDIVIDUAL DOLLAR LIMITATION. The aggregate Fair Market Value (determined as of the time an Award is made) of all shares of Stock with respect to which Incentive Stock Options are first exercisable by a Participant in any calendar year
may not exceed $100,000.00. 
  
 (e) TEN PERCENT
OWNERS. No Incentive Stock Option shall be granted to any individual who, at the date of grant, owns stock possessing more than ten percent of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary unless
the exercise price per share of such Option is at least 110% of the Fair Market Value per share of Stock at the date of grant and the Option expires no later than five years after the date of grant. 
  

 8 

 (f) EXPIRATION OF INCENTIVE STOCK OPTIONS. No Award of an Incentive Stock Option may be
made pursuant to the Plan after the day immediately prior to the tenth anniversary of the Effective Date. 
  
 (g) RIGHT TO EXERCISE. During a Participant’s lifetime, an Incentive Stock Option may be exercised only by the Participant or, in the
case of the Participant’s Disability, by the Participant’s guardian or legal representative. 
  
 (h) DIRECTORS. The Committee may not grant an Incentive Stock Option to a non-employee director. The Committee may grant an Incentive
Stock Option to a director who is also an employee of the Company or Parent or Subsidiary but only in that individual’s position as an employee and not as a director. 
  
 ARTICLE 8 
 STOCK APPRECIATION RIGHTS 
  
 8.1. GRANT OF SARs.
The Committee is authorized to grant SARs to Participants on the following terms and conditions: 
  
 (a) RIGHT TO PAYMENT. Upon the exercise of a Stock Appreciation Right, the Participant to whom it is granted has the right to receive the
excess, if any, of: 
  
 (1) The Fair Market Value
of one share of Stock on the date of exercise; over 
  
 (2) The grant price of the Stock Appreciation Right as determined by the Committee, which shall not be less than the Fair Market Value of one share of Stock on the date of grant in the case of any SAR related to an Incentive Stock Option.

  
 (b) OTHER TERMS. All awards of Stock
Appreciation Rights shall be evidenced by an Award Agreement. The terms, methods of exercise, methods of settlement, form of consideration payable in settlement, and any other terms and conditions of any Stock Appreciation Right shall be determined
by the Committee at the time of the grant of the Award and shall be reflected in the Award Agreement. 
  
 ARTICLE 9 
 PERFORMANCE SHARES 
  
 9.1. GRANT OF PERFORMANCE SHARES. The Committee is authorized to grant
Performance Shares to Participants on such terms and conditions as may be selected by the Committee. The Committee shall have the complete discretion to determine the number of Performance Shares granted to each Participant. All Awards of
Performance Shares shall be evidenced by an Award Agreement. 
  

 9 

 9.2. RIGHT TO PAYMENT. A grant of Performance Shares gives the Participant rights, valued as determined
by the Committee, and payable to, or exercisable by, the Participant to whom the Performance Shares are granted, in whole or in part, as the Committee shall establish at grant or thereafter. The Committee shall set performance goals and other terms
or conditions to payment of the Performance Shares in its discretion which, depending on the extent to which they are met, will determine the number and value of Performance Shares that will be paid to the Participant. 
  
 9.3. OTHER TERMS. Performance Shares may be payable in cash, Stock, or other
property, and have such other terms and conditions as determined by the Committee and reflected in the Award Agreement. 
  
 ARTICLE 10 
 RESTRICTED STOCK AWARDS

  
 10.1. GRANT OF RESTRICTED STOCK. The Committee is
authorized to make Awards of Restricted Stock to Participants in such amounts and subject to such terms and conditions as may be selected by the Committee. All Awards of Restricted Stock shall be evidenced by a Restricted Stock Award Agreement.

  
 10.2. ISSUANCE AND RESTRICTIONS. Restricted Stock shall be
subject to such restrictions on transferability and other restrictions as the Committee may impose (including, without limitation, limitations on the right to vote Restricted Stock or the right to receive dividends on the Restricted Stock). These
restrictions may lapse separately or in combination at such times, under such circumstances, in such installments, upon the satisfaction of performance goals or otherwise, as the Committee determines at the time of the grant of the Award or
thereafter. 
  
 10.3. FORFEITURE. Except as otherwise determined
by the Committee at the time of the grant of the Award or thereafter, upon termination of employment during the applicable restriction period or upon failure to satisfy a performance goal during the applicable restriction period, Restricted Stock
that is at that time subject to restrictions shall be forfeited and reacquired by the Company; provided, however, that the Committee may provide in any Award Agreement that restrictions or forfeiture conditions relating to Restricted Stock will be
waived in whole or in part in the event of terminations resulting from specified causes, and the Committee may in other cases waive in whole or in part restrictions or forfeiture conditions relating to Restricted Stock. 
  
 10.4. CERTIFICATES FOR RESTRICTED STOCK. Restricted Stock granted under the
Plan may be evidenced in such manner as the Committee shall determine. If certificates representing shares of Restricted Stock are registered in the name of the Participant, certificates must bear an appropriate legend referring to the terms,
conditions, and restrictions applicable to such Restricted Stock. 
  

 10 

 ARTICLE 11 
 DIVIDEND EQUIVALENTS 
  
 11.1 GRANT OF DIVIDEND EQUIVALENTS. The Committee is authorized to grant Dividend Equivalents to Participants subject to such terms and conditions as may be selected by the Committee. Dividend Equivalents shall entitle the Participant to
receive payments equal to dividends with respect to all or a portion of the number of shares of Stock subject to an Award, as determined by the Committee. The Committee may provide that Dividend Equivalents be paid or distributed when accrued or be
deemed to have been reinvested in additional shares of Stock, or otherwise reinvested. 
  
 ARTICLE 12 
 OTHER STOCK-BASED AWARDS 
  
 12.1. GRANT OF OTHER STOCK-BASED AWARDS. The Committee is authorized, subject
to limitations under applicable law, to grant to Participants such other Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to shares of Stock, as deemed by the Committee to be consistent with
the purposes of the Plan, including without limitation shares of Stock awarded purely as a “bonus” and not subject to any restrictions or conditions, convertible or exchangeable debt securities, other rights convertible or exchangeable
into shares of Stock, and Awards valued by reference to book value of shares of Stock or the value of securities of or the performance of specified Parents or Subsidiaries. The Committee shall determine the terms and conditions of such Awards.

  
 ARTICLE 13 
 PROVISIONS APPLICABLE TO AWARDS 
  
 13.1. STAND-ALONE, TANDEM, AND SUBSTITUTE AWARDS. Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in
addition to, in tandem with, or in substitution for, any other Award granted under the Plan. If an Award is granted in substitution for another Award, the Committee may require the surrender of such other Award in consideration of the grant of the
new Award. Awards granted in addition to or in tandem with other Awards may be granted either at the same time as or at a different time from the grant of such other Awards. 
  
 13.2. EXCHANGE PROVISIONS. The Committee may at any time offer to exchange or buy out any previously granted Award for a
payment in cash, Stock, or another Award (subject to Section 14.1), based on the terms and conditions the Committee determines and communicates to the Participant at the time the offer is made, and after taking into account the tax, securities and
accounting effects of such an exchange. 
  

 11 

 13.3. TERM OF AWARD. The term of each Award shall be for the period as determined by the Committee,
provided that in no event shall the term of any Incentive Stock Option or a Stock Appreciation Right granted in tandem with the Incentive Stock Option exceed a period of ten years from the date of its grant (or, if Section 7.2(e) applies, five years
from the date of its grant). 
  
 13.4. FORM OF PAYMENT FOR AWARDS.
Subject to the terms of the Plan and any applicable law or Award Agreement, payments or transfers to be made by the Company or a Parent or Subsidiary on the grant or exercise of an Award may be made in such form as the Committee determines at or
after the time of grant, including without limitation, cash, Stock, other Awards, or other property, or any combination, and may be made in a single payment or transfer, in installments, or on a deferred basis, in each case determined in accordance
with rules adopted by, and at the discretion of, the Committee. 
  
 13.5. LIMITS ON TRANSFER. No right or interest of a Participant in any unexercised or restricted Award may be pledged, encumbered, or hypothecated to or in favor of any party other than the Company or a Parent or Subsidiary, or shall be
subject to any lien, obligation, or liability of such Participant to any other party other than the Company or a Parent or Subsidiary. No unexercised or restricted Award shall be assignable or transferable by a Participant other than by will or the
laws of descent and distribution or, except in the case of an Incentive Stock Option, pursuant to a domestic relations order that would satisfy Section 414(p)(1)(A) of the Code if such Section applied to an Award under the Plan; provided, however,
that the Committee may (but need not) permit other transfers where the Committee concludes that such transferability (i) does not result in accelerated taxation, (ii) does not cause any Option intended to be an incentive stock option to fail to be
described in Code Section 422(b), and (iii) is otherwise appropriate and desirable, taking into account any factors deemed relevant, including without limitation, state or federal tax or securities laws applicable to transferable Awards. 

 
 13.6 BENEFICIARIES. Notwithstanding Section 13.5, a Participant may, in
the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant and to receive any distribution with respect to any Award upon the Participant’s death. A beneficiary, legal guardian, legal
representative, or other person claiming any rights under the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Participant, except to the extent the Plan and Award Agreement otherwise provide, and to
any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or survives the Participant, payment shall be made to the Participant’s estate. Subject to the foregoing, a beneficiary
designation may be changed or revoked by a Participant at any time provided the change or revocation is filed with the Committee. 
  
 13.7. STOCK CERTIFICATES. All Stock certificates delivered under the Plan are subject to any stop-transfer orders and other restrictions as the Committee
deems necessary or advisable to comply with federal or state securities laws, rules and regulations and the rules of any national securities exchange or automated quotation system on which the Stock is listed, quoted, or traded. The Committee may
place legends on any Stock certificate to reference restrictions applicable to the Stock. 
  

 12 

 13.8 ACCELERATION UPON DEATH OR DISABILITY. Notwithstanding any other provision in the Plan or any
Participant’s Award Agreement to the contrary, upon the Participant’s death or Disability during his employment or service as a director, all outstanding Options, Stock Appreciation Rights, and other Awards in the nature of rights that may
be exercised shall become fully exercisable and all restrictions on outstanding Awards shall lapse. Any Option or Stock Appreciation Rights Awards shall thereafter continue or lapse in accordance with the other provisions of the Plan and the Award
Agreement. To the extent that this provision causes Incentive Stock Options to exceed the dollar limitation set forth in Section 7.2(d), the excess Options shall be deemed to be Non-Qualified Stock Options. 
  
 13.9. ACCELERATION FOR ANY OTHER REASON. The Committee may in its sole
discretion at any time determine that all or a portion of a Participant’s Options, Stock Appreciation Rights, and other Awards in the nature of rights that may be exercised shall become fully or partially exercisable, and/or that all or a part
of the restrictions on all or a portion of the outstanding Awards shall lapse, in each case, as of such date as the Committee may, in its sole discretion, declare. The Committee may discriminate among Participants and among Awards granted to a
Participant in exercising its discretion pursuant to this Section 13.9. 
  
 13.10 EFFECT OF ACCELERATION. If an Award is accelerated under Section 13.9, the Committee may, in its sole discretion, provide (i) that the Award will expire after a designated period of time after such acceleration to the extent not then
exercised, (ii) that the Award will be settled in cash rather than Stock, (iii) that the Award will be assumed by another party to a transaction giving rise to the acceleration or otherwise be equitably converted in connection with such transaction,
or (iv) any combination of the foregoing. The Committee’s determination need not be uniform and may be different for different Participants whether or not such Participants are similarly situated. 
  
 13.11 RETIREMENT. Notwithstanding any other provision in the Plan or any
Participant’s Award Agreement to the contrary, upon the Participant’s Retirement (as defined in Section 3.1), all outstanding Options, Stock Appreciation Rights, and other Awards in the nature of rights that may be exercised shall become
fully exercisable and all restrictions on outstanding Awards shall lapse. Any Options or Stock Appreciation Rights held by the Participant shall remain exercisable until the earlier of (i) the original expiration date of the Option, or (ii) the
fifth anniversary of the Participant’s Retirement. To the extent that this provision causes any Incentive Stock Options to fail to meet the requirements of Code Section 422, such Options shall be deemed to be Non-Qualified Stock Options.

  

 13 

 13.12. PERFORMANCE GOALS. The Committee may determine that any Award granted pursuant to this Plan to a
Participant (including, but not limited to, Participants who are Covered Employees) shall be determined solely on the basis of (a) the achievement by the Company or a Parent or Subsidiary of a specified target return, or target growth in return, on
equity or assets, (b) the Company’s stock price, (c) the Company’s total stockholder return (stock price appreciation plus reinvested dividends) relative to a defined comparison group or target over a specific performance period, (d) the
achievement by a business unit of the Company, Parent or Subsidiary of a specified target, or target growth in, revenue, profit contribution, net income, EBIT, EBITDA or earnings per share, (e) the achievement by a business unit of the Company,
Parent or Subsidiary of a specified target, or target growth in, operating income and or margin percentage of revenue, or (f) any combination of the goals set forth in (a) through (e) above. Further, the performance goal may be stated in terms of a
dollar amount, a percentage increase, a target percentage or as an amount or percent of change over time. If an Award is made on such basis, the Committee has the right for any reason to reduce (but not increase) the Award, notwithstanding the
achievement of a specified goal. If an Award is made on such basis, the Committee shall establish goals prior to the beginning of the period for which such performance goal relates (or such later date as may be permitted under Code Section 162(m) or
the regulations thereunder). Any payment of an Award granted with performance goals shall be conditioned on the written certification of the Committee in each case that the performance goals and any other material conditions were satisfied.

  
 13.13. TERMINATION OF EMPLOYMENT. Whether military, government
or other service or other leave of absence shall constitute a termination of employment shall be determined in each case by the Committee at its discretion, and any determination by the Committee shall be final and conclusive. A termination of
employment shall not occur in a circumstance in which a Participant transfers from the Company to one of its Parents or Subsidiaries, transfers from a Parent or Subsidiary to the Company, or transfers from one Parent or Subsidiary to another Parent
or Subsidiary. 
  
 ARTICLE 14 
 CHANGES IN CAPITAL STRUCTURE 
  
 14.1. GENERAL. In the event of a corporate transaction involving the Company (including, without limitation, any stock dividend, stock split,
extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination or exchange of shares), the authorization limits under Section 5.1 and 5.4 shall be adjusted proportionately, and the Committee may
adjust Awards to preserve the benefits or potential benefits of the awards. Action by the Committee may include: (i) adjustment of the number and kind of shares which may be delivered under the Plan; (ii) adjustment of the number and kind of shares
subject to outstanding Awards; (iii) adjustment of the exercise price of outstanding Awards; and (iv) any other adjustments that the Committee determines to be equitable. Without limiting the foregoing, in the event a stock dividend or stock split
is declared upon the Stock, the authorization limits under Section 5.1 and 5.4 shall be increased proportionately, and the shares of Stock then subject to each Award shall be increased proportionately without any change in the aggregate purchase
price therefor. 
  

 14 

 ARTICLE 15 
 AMENDMENT, MODIFICATION AND TERMINATION 
  
 15.1. AMENDMENT, MODIFICATION AND TERMINATION. The Board or the Committee may, at any time and from time to time, amend, modify or terminate the Plan without stockholder approval; provided, however, that the Board or
Committee may condition any amendment or modification on the approval of stockholders of the Company if such approval is necessary or deemed advisable with respect to tax, securities or other applicable laws, policies or regulations. 
  
 15.2 AWARDS PREVIOUSLY GRANTED. At any time and from time to time, the
Committee may amend, modify or terminate any outstanding Award without approval of the Participant; provided, however, that, subject to the terms of the applicable Award Agreement, such amendment, modification or termination shall not, without the
Participant’s consent, reduce or diminish the value of such Award determined as if the Award had been exercised, vested, cashed in or otherwise settled on the date of such amendment or termination. No termination, amendment, or modification of
the Plan shall adversely affect any Award previously granted under the Plan, without the written consent of the Participant. 
  
 ARTICLE 16 
 GENERAL PROVISIONS

  
 16.1. NO RIGHTS TO AWARDS. No Participant or any eligible
participant shall have any claim to be granted any Award under the Plan, and neither the Company nor the Committee is obligated to treat Participants or eligible participants uniformly. 
  
 16.2. NO STOCKHOLDER RIGHTS. No Award gives the Participant any of the rights of a stockholder of the Company unless and
until shares of Stock are in fact issued to such person in connection with such Award. 
  
 16.3. WITHHOLDING. The Company or any Parent or Subsidiary shall have the authority and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal,
state, and local taxes (including the Participant’s FICA obligation) required by law (including any foreign jurisdiction in which the Participant resides) to be withheld with respect to any taxable event arising as a result of the Plan. With
respect to withholding required upon any taxable event under the Plan, the Committee may, at the time the Award is granted or thereafter, require or permit that any such withholding requirement be satisfied, in whole or in part, by withholding from
the Award shares of Stock having a Fair Market Value on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes, all in accordance with such procedures as the Committee establishes.

  

 15 

 16.4. NO RIGHT TO CONTINUED SERVICE. Nothing in the Plan or any Award Agreement shall interfere with or
limit in any way the right of the Company or any Parent or Subsidiary to terminate any Participant’s employment or status as an officer or director at any time, nor confer upon any Participant any right to continue as an employee, officer or
director of the Company or any Parent or Subsidiary. 
  
 16.5.
UNFUNDED STATUS OF AWARDS. The Plan is intended to be an “unfunded” plan for incentive and deferred compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award
Agreement shall give the Participant any rights that are greater than those of a general creditor of the Company or any Parent or Subsidiary. 
  
 16.6. INDEMNIFICATION. To the extent allowable under applicable law, each member of the Committee shall be indemnified and held harmless by the Company
from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or resulting from any claim, action, suit, or proceeding to which such member may be a party or in which he may be involved
by reason of any action or failure to act under the Plan and against and from any and all amounts paid by such member in satisfaction of judgment in such action, suit, or proceeding against him provided he gives the Company an opportunity, at its
own expense, to handle and defend the same before he undertakes to handle and defend it on his own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled
under the Company’s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 
  
 16.7. RELATIONSHIP TO OTHER BENEFITS. No payment under the Plan shall be taken into account in determining any benefits
under any pension, retirement, savings, profit sharing, group insurance, welfare or benefit plan of the Company or any Parent or Subsidiary unless provided otherwise in such other plan. 
  
 16.8. EXPENSES. The expenses of administering the Plan shall be borne by the Company and its Parents or Subsidiaries.

  
 16.9. TITLES AND HEADINGS. The titles and headings of the
Sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control. 
  
 16.10. GENDER AND NUMBER. Except where otherwise indicated by the context, any masculine term used herein also shall include
the feminine; the plural shall include the singular and the singular shall include the plural. 
  

 16 

 16.11. FRACTIONAL SHARES. No fractional shares of Stock shall be issued and the Committee shall
determine, in its discretion, whether cash shall be given in lieu of fractional shares or whether such fractional shares shall be eliminated by rounding up. 
  
 16.12. GOVERNMENT AND OTHER REGULATIONS. The obligation of the Company to make payment of awards in Stock or otherwise shall be subject to all applicable
laws, rules, and regulations, and to such approvals by government agencies as may be required. The Company shall be under no obligation to register under the 1933 Act, or any state securities act, any of the shares of Stock issued in connection with
the Plan. The shares issued in connection with the Plan may in certain circumstances be exempt from registration under the 1933 Act, and the Company may restrict the transfer of such shares in such manner as it deems advisable to ensure the
availability of any such exemption. 
  
 16.13. GOVERNING LAW. To
the extent not governed by federal law, the Plan and all Award Agreements shall be construed in accordance with and governed by the laws of the State of Delaware. 
  
 16.14 ADDITIONAL PROVISIONS. Each Award Agreement may contain such other terms and conditions as the Committee may
determine; provided that such other terms and conditions are not inconsistent with the provisions of this Plan. 
  
 16.15 TERMINATION OF PLAN. The Plan shall terminate on October 27, 2009, which is ten (10) years after the date on which the stockholders of the Company
approved the Plan. The termination of the Plan on such date shall not affect the validity of any Award outstanding on the date of termination. 
  
 The foregoing is hereby acknowledged as being the NDCHealth Corporation 2000 Long-Term Incentive Plan as approved by the stockholders of the Company on
October 28, 1999, as amended and restated by the Board of Directors on September 19, 2000, December 19, 2000, and September 23, 2003. 
  

			
	NDCHEALTH CORPORATION
		
	By:	 	 /s/    Margaret T. Wilkinson

	 	 	

	 	 	 Margaret T. Wilkinson
 General Counsel and Corporate
Secretary

  

 17Employment Agreement

 Exhibit 10(xli) 

  
 EMPLOYMENT AGREEMENT 
  
 BETWEEN 
  
 LEE ADREAN 
  
 AND 
  
 NDCHEALTH CORPORATION 
  
 Dated: May 11, 2004 
  

 EMPLOYMENT AGREEMENT 
  
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this 11 day of May, 2004 by and between
NDCHealth Corporation, a Delaware corporation with its principal executive offices located in Atlanta, Georgia (the “Company”), and Lee Adrean, an individual resident of Georgia, (“Executive”), to be effective as of the Effective
Date, as defined in Section 1. 
  
 BACKGROUND 
  
 Executive and the Company desire to memorialize in this Agreement the terms
of Executive’s employment with the Company. 
  
 NOW
THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  
 1. Effective Date. The effective date of this Agreement (the
“Effective Date”) is May 11, 2004. 
  
 2.
Employment. Executive is hereby employed as the Executive Vice President, Chief Financial Officer of the Company. In such capacity, Executive will have the responsibilities commensurate with such position as will be assigned to him by the
Chief Executive Officer of the Company, in accordance with the policies and objectives established by the Board of Directors of the Company (the “Board”). Executive’s reporting responsibilities will be to the Chief Executive Officer
or such other executive officer that the Chief Executive Officer may designate from time to time. 
  
 3. Employment Period. Executive’s employment hereunder will begin on the Effective Date and end on the third anniversary of the Effective
Date, unless extended as hereinafter provided in this Section 3 or terminated in accordance with the provisions of Section 7 (the “Employment Period”). As of the third anniversary of the Effective Date and on each succeeding anniversary of
the Effective Date during the Employment Period, Executive’s Employment Period will automatically be extended by one year so as to end on the next anniversary of the Effective Date, unless the Company otherwise provides Executive with written
notice of non-renewal at least 60 days prior to the third anniversary of the Effective Date or, following any automatic extension, any succeeding anniversary of the Effective Date. 
  
 4. Extent of Service. During the Employment Period, Executive will render his services to the Company (or to its
successor following a Change in Control, as defined below) in conformity with professional standards, in a prudent and workmanlike manner and in a manner consistent with the obligations imposed on officers of corporations under applicable law.
Executive will promote the interests of the Company and its subsidiaries and affiliated entities in carrying out Executive’s duties and will not deliberately take any 

  

 
action which could, or fail to take any action which failure could, reasonably be expected to have a material adverse effect upon the business of the Company
or any of its subsidiaries or any of their respective affiliates. Executive agrees to devote his business time, attention, skill and efforts exclusively to the faithful performance of his duties hereunder (both before and after a Change in Control);
provided, however, that it will not be a violation of this Agreement for Executive to (i) devote reasonable periods of time to charitable and community activities and, with the approval of the Company, industry or professional activities, and/or
(ii) manage personal investments, so long as such activities do not materially interfere with the performance of Executive’s responsibilities under this Agreement. 
  
 5. Compensation and Benefits. 
  
 (a) Base Salary. During the Employment Period, Executive will be entitled to receive a base salary in
the amount of $400,000 per year (“Base Salary”), less normal withholdings, payable in equal bi-weekly installments or other installments as are customary under the Company’s payroll practices from time to time. The Compensation
Committee of the Board will review Executive’s Base Salary periodically and in its sole discretion, subject to approval of the Board, may increase Executive’s Base Salary from time to time. The periodic review of Executive’s salary by
the Board will consider, among other things, Executive’s own performance and the Company’s performance. 
  
 (b) Incentive and Savings Plans. During the Employment Period, Executive will be entitled to participate in incentive and savings
plans, practices, policies and programs applicable generally to employees of the Company. Certain executive programs will be made available on a selective basis at the discretion of the Chief Executive Officer (the “CEO”) or the
Compensation Committee of the Board. Without limiting the foregoing, the following will apply: 
  
 (i) Annual Bonus. Executive will have an annual bonus opportunity of not less than $200,000, based on 100% achievement of financial
objectives established by the CEO or his designee (“Bonus Opportunity”). The annual Bonus Opportunity and specific performance objectives will be set forth in Executive’s individual performance and incentive plan for each year.

  
 (ii) Incentive Awards. On or about the
Effective Date (or earlier upon Executive’s hire date), the Company made a grant of restricted stock, stock options, restricted stock units, stock appreciation rights and/or similar stock-based awards to Executive as a long-term incentive for
performance and in consideration for entering into this Agreement. Further grants of incentive awards may be made to Executive in future years at the discretion of the Compensation Committee of the Board. 
  
 (c) Welfare Benefit Plans. During the Employment
Period, Executive and Executive’s family will be eligible for participation in, and will receive all benefits under, the welfare benefit plans, practices, policies and programs provided by the Company 

  

 - 2 - 

 
(including, without limitation, medical, prescription, dental, disability, employee life, group life, accidental death and travel accident insurance plans
and programs), subject to the same terms that such benefits are made available to other senior executives of the Company generally. 
  
 (d) Expenses. During the Employment Period, Executive will be entitled to receive prompt reimbursement for all reasonable expenses
incurred by Executive in accordance with the policies, practices and procedures of the Company. 
  
 (e) Fringe Benefits. During the Employment Period, Executive will be entitled to fringe benefits in accordance with the plans,
practices, programs and policies of the Company. 
  
 6. Change
in Control. For the purposes of this Agreement, a “Change in Control” means: 
  
 (a) The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of the combined voting power of the then outstanding voting
securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (a), the following acquisitions will not constitute a
Change in Control: (i) any acquisition by a Person who is on the Effective Date the beneficial owner of 35% or more of the Outstanding Company Voting Securities, (ii) any acquisition directly from the Company, (iii) any acquisition by the Company
which reduces the number of Outstanding Company Voting Securities and thereby results in any Person having beneficial ownership of more than 35% of the Outstanding Company Voting Securities, (iv) any acquisition by any employee benefit plan (or
related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (v) any acquisition by any corporation pursuant to a transaction which complies with clauses (i) and (ii) of subsection (b) of this Section 6; or

  
 (b) Consummation of a reorganization, merger
or consolidation or sale or other disposition of all or substantially all of the assets of the Company (a “Business Combination”), in each case, unless, following such Business Combination, (i) outstanding Company common stock (or
outstanding securities issued by a surviving entity in exchange therefore) constitutes more than 50% of the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in
the election of directors, as the case may be, of the corporation resulting from such Business Combination, and (ii) no Person (excluding the Company or any employee benefit plan (or related trust) of the Company or such corporation resulting from
such Business Combination) beneficially owns, directly or indirectly, 35% or more of the combined voting power of the then outstanding voting 

  

 - 3 - 

 
securities of such corporation except to the extent that such ownership existed prior to the Business Combination; or 
  
 (c) The election of a majority of the members of the Board,
without the recommendation or approval by a majority of the existing Board members; or 
  
 (d) The shareholders of the Company approve a plan of complete liquidation or dissolution of the Company (other than by a reorganization,
merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company); provided, however, that 
  
 (e) Notwithstanding anything in this definition to the contrary, a restructuring and/or separation of any line of business or business
unit from the Company will not of itself constitute a Change in Control; provided further that 
  
 (f) For the avoidance of doubt, the term “Person” as used in this Section 6 includes the shareholders of a corporation or other
entity that is a party to a merger, consolidation or business combination to which the Company also is a party, including a forward or reverse subsidiary merger pursuant to which voting securities of the Company are issued to such shareholders.

  
 7. Termination of Employment. 
  
 (a) Death, Retirement or Disability. Executive’s
employment and the Employment Period will terminate automatically upon Executive’s death or Retirement. For purposes of this Agreement, “Retirement” means normal retirement as defined in the Company’s then-current retirement
plan, or if there is no such retirement plan, “Retirement” means voluntary termination after age 65 with ten years of service. If the Company determines in good faith that a Disability of Executive has occurred (pursuant to the definition
of Disability set forth below), it may give to Executive written notice of its intention to terminate Executive’s employment. In such event, Executive’s employment with the Company will terminate effective on the 30th day after receipt of
such written notice by Executive (the “Disability Effective Date”), provided that, within the 30 days after such receipt, Executive has not returned to full-time performance of Executive’s duties or Executive consistently fails to
meet reasonable expectations in his work performance due to any incapacity resulting from a physical or mental illness. For purposes of this Agreement, “Disability” means a mental or physical disability as determined by the Board in
accordance with standards and procedures similar to those under the Company’s employee long-term disability plan, if any. At any time that the Company does not maintain such a long-term disability plan, Disability will mean the inability of
Executive, as determined by the Board, to substantially perform the essential functions of his regular duties and responsibilities due to a medically determinable physical or mental illness which has lasted (or can reasonably be expected to last)
for a period of six consecutive months. 
  

 - 4 - 

 (b) Termination by the Company. The Company may terminate Executive’s
employment for Poor Performance or with or without Cause. For purposes of this Agreement: 
  
 “Poor Performance” means the consistent failure of Executive to meet reasonable performance expectations (other than any such
failure resulting from incapacity due to physical or mental illness); provided, however, that termination for Poor Performance will not be effective unless at least 30 days prior to such termination Executive has received written notice from the CEO
or the Board which specifically identifies the manner in which the CEO or the Board believes that Executive has not met performance expectations and Executive has failed after receipt of such notice to resume the diligent performance of his duties
to the satisfaction of the CEO or the Board; and 
  
 “Cause” means: 
  
 (i) the
willful and continued failure of Executive to perform substantially Executive’s duties with the Company (other than any such failure resulting from incapacity due to physical or mental illness, and specifically excluding any failure by
Executive, after reasonable efforts, to meet performance expectations), after a written demand for substantial performance is delivered to Executive by the President of the Company, the CEO or the Board which specifically identifies the manner in
which such Board or officer believes that Executive has not substantially performed Executive’s duties, or 
  
 (ii) any act of fraud, misappropriation, embezzlement or similar dishonest or wrongful act by Executive, or 
  
 (iii) Executive’s abuse of alcohol or any substance
which materially interferes with Executive’s ability to perform services on behalf of the Company, or 
  
 (iv) Executive’s conviction for, or plea of guilty or nolo contendere to, a felony, or 
  
 (v) Executive’s acceptance of employment with an
employer other than the Company or any subsidiary of the Company. 
  
 (c) Termination by Executive. Executive’s employment may be terminated by Executive for Good Reason or no reason. For purposes of this Agreement, “Good Reason” means: 
  
 (i) without the written consent of Executive, the assignment
to Executive of any duties materially inconsistent with Executive’s position (including offices, titles and reporting requirements), authority, duties or responsibilities as in effect on the Effective Date, or any other action by the Company
which results in a material diminution in such position, authority, duties or responsibilities, excluding for this 

  

 - 5 - 

 
purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice
thereof given by Executive; 
  
 (ii) a reduction
by the Company in Executive’s Base Salary or benefits as in effect on the Effective Date or as the same may be increased from time to time, unless a similar reduction is made in salary or benefits of all senior executives of the Company (or any
of its subsidiaries and any of their respective affiliates with respect to which the Company exerts control over compensation policies), but in no event shall such reduction be to a level less than 75% of Executive’s initial Base Salary or 75%
of his initial Bonus Opportunity or shall benefits be reduced to a level less that that offered to the general employee base of the Company without such reduction being considered “Good Reason”; 
  
 (iii) the Company’s requiring Executive, without his
consent, to be based at any office or location other than in the greater metropolitan area of the city in which his office is located at the Effective Date or 
  

(iv) any failure by the Company to comply with and satisfy Section 16(c) of this Agreement. 
  
 (d) Notice of Termination. Any termination by the
Company for Poor Performance or Cause, or by Executive for Good Reason, will be communicated by Notice of Termination to the other party hereto given in accordance with Section 17(f) of this Agreement. For purposes of this Agreement, a “Notice
of Termination” means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis
for termination of Executive’s employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date will be not more
than 30 days after the giving of such notice). The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason, Poor Performance or Cause will not waive any
right of Executive or the Company, respectively, hereunder or preclude Executive or the Company, respectively, from asserting such fact or circumstance in enforcing Executive’s or the Company’s rights hereunder. 
  
 (e) Date of Termination. “Date of
Termination” means (i) if Executive’s employment is terminated other than by reason of death, Disability or Retirement, the date of receipt of the Notice of Termination, or any later date specified therein (which will not be more than 30
days after the date of delivery of the Notice of Termination), or (ii) if Executive’s employment is terminated by reason of death, Disability or Retirement, the Date of Termination will be the date of death or Retirement, or the Disability
Effective Date, as the case may be. In no event will the Date of Termination be after the end of Executive’s Employment Period, as provided for in Section 3 of this Agreement. 
  

 - 6 - 

 8. Obligations of the Company upon Termination. 
  
 (a) Upon Normal Expiration of Employment Period. Upon
the expiration of Executive’s Employment Period, as described in Section 3: 
  
 (i) the Company will pay to Executive in a lump sum in cash within 30 days after the expiration of his Employment Period the sum of (A)
Executive’s Base Salary through the expiration of his Employment Period to the extent not theretofore paid, and (B) any accrued vacation pay to the extent not theretofore paid; and 
  
 (ii) to the extent not theretofore paid or provided, the Company will timely pay or provide to Executive any
other amounts or benefits required to be paid or provided or which Executive is eligible to receive under any plan, program, policy or practice or contract or agreement of the Company, including any rights to which he is entitled under the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), (such other amounts and benefits will be hereinafter referred to as the “Other Benefits”). 
  
 (b) Prior to a Change in Control: Termination by
Executive for Good Reason; Termination by the Company Other Than for Poor Performance, Cause or Disability. If, prior to a Change in Control and during the Executive’s Employment Period, the Company terminates Executive’s employment
other than for Poor Performance, Cause or Disability, or Executive terminates employment for Good Reason within a period of 90 days after the occurrence of the event giving rise to Good Reason, then (and with respect to the payments and benefits
described in clauses (ii) through (vii) below, only if Executive executes a Release in substantially the form of Exhibit A hereto (the “Release”)): 
  

(i) the Company will pay to Executive in a lump sum in cash within 30 days after the Date of Termination the sum of (A)
Executive’s Base Salary through the Date of Termination to the extent not theretofore paid, and (B) any accrued vacation pay to the extent not theretofore paid (the sum of the amounts described in clauses (A) and (B) will be hereinafter
referred to as the “Accrued Obligations”); and 
  
 (ii) for the longer of six months or until Executive becomes employed with a subsequent employer, but in no event to exceed the lesser of (A) 18 months from the Date of Termination or (B) the remaining term of
Executive’s Employment Period (the “Normal Severance Period”), the Company will continue to pay Executive an amount equal to his monthly Base Salary, payable in equal monthly or more frequent installments as are customary under the
Company’s payroll practices from time to time; provided, however, that the Company’s obligation to make or continue such payments will cease if Executive violates any of the Restrictive Covenants (as defined in Section 13(b) of this
Agreement) and fails to remedy such violation to the satisfaction of the Board within 10 days of notice of such violation; and 
  

 - 7 - 

 (iii) during the Normal Severance Period, if and to the extent Executive timely elects
COBRA continuation coverage, the Company will pay for the full premium amount of such COBRA continuation coverage and will impute taxable income to the Executive equal to the full premium amount; provided, however that the Company’s obligation
to provide such benefits will cease if Executive violates any of the Restrictive Covenants (as defined in Section 13(b) of this Agreement) and fails to remedy such violation to the satisfaction of the Board within 10 days of notice of such
violation; provided further, that to the extent Executive continues COBRA continuation coverage beyond his Normal Severance Period, Executive will be responsible for paying the full cost of the COBRA continuation coverage in accordance with the
procedures of the Company generally applicable to all qualified beneficiaries receiving COBRA continuation coverage; and 
  
 (iv) not later than 30 days after the Date of Termination, Executive will be paid a bonus for the year in which the Date of Termination
occurs in a lump sum cash amount equal to 100% of his Bonus Opportunity (prorated through the Date of Termination) adjusted up or down by reference to his year-to-date performance at the Date of Termination in relation to the prior established
performance objectives under Executive’s bonus plan for such year; provided, however that the bonus payment described in this Section 8(b)(iv) will be reduced by the amount (if any) of the Bonus Opportunity that Executive had previously elected
to receive in the form of restricted stock of the Company; and 
  
 (v) all grants of restricted stock, restricted stock units and similar Company stock-based awards (“Restricted Stock”) held by Executive as of the Date of Termination will become immediately vested as of the
Date of Termination; and 
  
 (vi) all of
Executive’s options to acquire Common Stock of the Company, stock appreciation rights in Common Stock of the Company and similar Company stock-based awards (“Options”) that would have become vested (by lapse of time) within the
24-month period following the Date of Termination had Executive remained employed during such period will become immediately vested as of the Date of Termination; and 
  
 (vii) notwithstanding the provisions of the applicable Option agreement, all of Executive’s vested but
unexercised Options as of the Date of Termination (including those with accelerated vesting pursuant to Section 8(b)(vi) above) will remain exercisable through the earlier of (A) the original expiration date of the Option, or (B) the 90th day following the end of the Normal Severance Period; and 
  
 (viii) to the extent not theretofore paid or provided, the Company will timely pay or provide to Executive
his Other Benefits. 
  
 (c) Prior to a Change
in Control: Termination by the Company for Poor Performance. If, prior to the occurrence of a Change in Control, the Company terminates 

  

 - 8 - 

 
Executive’s employment for Poor Performance, then (and with respect to the payments and benefits described in clauses (ii) through (vii) below, only if
Executive executes the Release): 
  
 (i) the
Company will pay to Executive the Accrued Obligations in a lump sum in cash within 30 days after the Date of Termination; and 
  
 (ii) for the shortest of 12 months after the Date of Termination, the remaining term of Executive’s Employment Period, or until
Executive becomes employed with a subsequent employer (the “Poor Performance Severance Period”), the Company will continue to pay Executive an amount equal to his monthly Base Salary, payable in equal bi-weekly installments or more
frequent installments as are customary under the Company’s payroll practices from time to time; provided, however that the Company’s obligation to make or continue such payments will cease if Executive violates any of the Restrictive
Covenants (as defined in Section 13(b) of this Agreement) and fails to remedy such violation to the satisfaction of the Board within 10 days of notice of such violation; and 
  
 (iii) during the Poor Performance Severance Period, if and to the extent Executive timely elects COBRA
continuation coverage, the Company will pay for the full premium amount of such COBRA continuation coverage and will impute taxable income to the Executive equal to the full premium amount; provided, however that the Company’s obligation to
provide such benefits will cease if Executive violates any of the Restrictive Covenants (as defined in Section 13(b) of this Agreement) and fails to remedy such violation to the satisfaction of the Board within 10 days of notice of such violation;
provided further, that to the extent Executive continues COBRA continuation coverage beyond his Poor Performance Severance Period, Executive will be responsible for paying the full cost of the COBRA continuation coverage in accordance with the
procedures of the Company generally applicable to all qualified beneficiaries receiving COBRA continuation coverage; and 
  
 (iv) the initial grant of Restricted Stock made to Executive in connection with his employment as referenced in Section 5(b)(ii) hereof
will become immediately vested as of the Date of Termination, and all other grants of Restricted Stock held by Executive as of the Date of Termination that would have become vested (by lapse of time) within the 12-month period following the Date of
Termination had Executive remained employed during such period will become immediately vested as of the Date of Termination; and 
  
 (v) all of Executive’s Options that would have become vested (by lapse of time) within the 12-month period following the Date of
Termination had Executive remained employed during such period will become immediately vested and exercisable as of the Date of Termination; and 
  

 - 9 - 

 (vi) notwithstanding the provisions of the applicable Option agreement, all of
Executive’s vested but unexercised Options as of the Date of Termination (including those with accelerated vesting pursuant to the Section 8(c)(vi) above) will remain exercisable through the earlier of (A) the original expiration date of the
Option, or (B) the 90th day following the end of the later of (1) six months from the Date of Termination, or (2)
the end of the Poor Performance Severance Period; and 
  
 (vii) to the extent not theretofore paid or provided, the Company will timely pay or provide to Executive his Other Benefits. 
  
 (d) After or in Connection with a Change in Control: Termination by Executive for Good Reason; Termination by the Company Other Than
for Cause or Disability. If a Change in Control occurs and, within 36 months following such Change in Control (or if Executive can reasonably show that such termination by the Executive or by the Company was in anticipation of the Change in
Control), the Company terminates Executive’s employment other than for Cause or Disability or does not extend the Employment Period as permitted under Section 3, or Executive terminates employment for Good Reason, then (and with respect to the
payments and benefits described in clauses (ii) through (vii) below, only if Executive executes the Release): 
  
 (i) the Company (or its successor) will pay to Executive the Accrued Obligations in a lump sum in cash within 30 days after the Date of
Termination; and 
  
 (ii) the Company (or its
successor) will pay to Executive a lump sum cash amount equal to 24 times his monthly Base Salary within 30 days after the Date of Termination; and 
  
 (iii) for 18 months after the Date of Termination, if and to the extent Executive timely elects COBRA continuation coverage, the Company
will pay for the full premium amount of such COBRA continuation coverage and will impute taxable income to the Executive equal to the full premium amount; provided, however that the Company’s obligation to provide such benefits will cease if
Executive violates any of the Restrictive Covenants (as defined in Section 13(b) of this Agreement) and fails to remedy such violation to the satisfaction of the Board within 10 days of notice of such violation; and 
  
 (iv) not later than 30 days after the Date of Termination,
Executive will be paid a lump sum cash amount equal to 100% of his Bonus Opportunity for the year in which the Date of Termination occurs (as defined in Section 5(b)(i)); provided, however that the total bonus payment described in this Section
8(d)(iv) will be reduced by the amount (if any) of the Bonus Opportunity that Executive had previously elected to receive in the form of restricted stock of the Company; and 
  
 (v) all grants of Restricted Stock held by Executive as of the Date of Termination will become immediately
vested as of the Date of Termination; and 
  

 - 10 - 

 (vi) all of Executive’s Options held by Executive as of the Date of Termination will
become immediately vested and exercisable as of the Date of Termination; and 
  
 (vii) notwithstanding the provisions of the applicable Option agreement, all of Executive’s vested but unexercised Options as of the Date of Termination (including those with accelerated vesting pursuant to the
Section 8(d)(vi) above) will remain exercisable through the earlier of (A) the original expiration date of the Option, or (B) the 90th day following the end of the 24-month period beginning on the Date of Termination; and 
  
 (viii) to the extent not theretofore paid or provided, the Company will timely pay or provide to Executive his Other Benefits; and

  
 (ix) the restrictions on Executive’s
conduct outlined in Section 13 of this Agreement will cease to apply. 
  
 (e) Death, Disability or Retirement. Regardless of whether or not a Change in Control has occurred, if Executive’s employment is terminated by reason of Executive’s death, Disability or Retirement,
this Agreement will terminate without further obligations to Executive or his estate or legal representatives under this Agreement, other than for payment of Accrued Obligations and the timely payment or provision of Other Benefits. Accrued
Obligations will be paid to Executive’s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination. With respect to the provision of Other Benefits, the term Other Benefits as used in this Section 8(e)
will include, without limitation, and Executive or his estate and/or beneficiaries will be entitled to receive, benefits under such plans, programs, practices and policies relating to death, disability or retirement benefits, if any, as are
applicable to Executive on the Date of Termination. 
  
 (f) Cause or Voluntary Termination without Good Reason. Regardless of whether or not a Change in Control has occurred, if Executive’s employment is terminated for Cause, or if Executive voluntarily terminates employment without
Good Reason, this Agreement will terminate without further obligations to Executive, other than for payment of Accrued Obligations and the timely payment or provision of Other Benefits. 
  
 9. Non-exclusivity of Rights. Nothing in this Agreement will prevent or limit Executive’s continuing or future
participation in any plan, program, policy or practice provided by the Company and for which Executive may qualify, nor, subject to Section 17(d), will anything herein limit or otherwise affect such rights as Executive may have under any contract or
agreement with the Company. Amounts which are vested benefits or which Executive is otherwise entitled to receive under any plan, policy, practice or program of the Company or under any contract or agreement with the Company at or 

  

 - 11 - 

 
subsequent to the Date of Termination will be payable in accordance with such plan, policy, practice or program or contract or agreement except as explicitly
modified by this Agreement. 
  
 10. Certain Additional Payments
by the Company. 
  
 (a) Anything in this
Agreement to the contrary notwithstanding and except as set forth below, in the event it will be determined that any payment or distribution by the Company to or for the benefit of Executive (whether paid or payable or distributed or distributable
pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional payments required under this Section 10) (a “Payment”) would be subject to the excise tax imposed by Section 4999 of the Code or any
interest or penalties are incurred by Executive with respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the “Excise Tax”), then Executive will be entitled
to receive an additional payment (a “Gross-Up Payment”) in an amount such that after payment by Executive of all taxes (including any interest or penalties imposed with respect to such taxes), including, without limitation, any income
taxes (and any interest and penalties imposed with respect thereto) and Excise Tax imposed upon the Gross-Up Payment, Executive retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments. Notwithstanding the
foregoing provisions of this Section 10(a), if it is determined that Executive is entitled to a Gross-Up Payment, but that Executive, after taking into account the Payments and the Gross-Up Payment, would not receive a net after-tax benefit of at
least $50,000 (taking into account both income taxes and any Excise Tax) as compared to the net after-tax proceeds to Executive resulting from an elimination of the Gross-Up Payment and a reduction of the Payments, in the aggregate, to an amount
(the “Reduced Amount”) such that the receipt of Payments would not give rise to any Excise Tax, then no Gross-Up Payment will be made to Executive and the Payments, in the aggregate, will be reduced to the Reduced Amount. In that event,
Executive will direct which Payments are to be modified or reduced. 
  
 (b) Subject to the provisions of Section 10(c), all determinations required to be made under this Section 10, including whether and when a Gross-Up Payment is required and the amount of such Gross-Up Payment and the
assumptions to be utilized in arriving at such determination, will be made by Ernst & Young LLP or such other certified public accounting firm reasonably acceptable to the Company as may be designated by Executive (the “Accounting
Firm”) which will provide detailed supporting calculations both to the Company and Executive within 15 business days of the receipt of notice from Executive that there has been a Payment, or such earlier time as is requested by the Company. In
the event that the accounting firm is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, or in the event that serving as the Accounting Firm for purposes of this Section 10(b) would jeopardize the
accounting firm’s status as the Company’s independent auditor, Executive will appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm will then be referred to as the
Accounting Firm 
  

 - 12 - 

 
hereunder). All fees and expenses of the Accounting Firm will be borne solely by the Company. Any Gross-Up Payment, as determined pursuant to this Section
10, will be paid by the Company to Executive within five days of the receipt of the Accounting Firm’s determination. Any determination by the Accounting Firm will be binding upon the Company and Executive. As a result of the uncertainty in the
application of Section 4999 of the Code at the time of the initial determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments which will not have been made by the Company should have been made (“Underpayment”),
consistent with the calculations required to be made hereunder. In the event that the Company exhausts its remedies pursuant to Section 10(c) and Executive thereafter is required to make a payment of any Excise Tax, the Accounting Firm will
determine the amount of the Underpayment that has occurred and any such Underpayment will be promptly paid by the Company to or for the benefit of Executive. 
  

(c) The Executive will notify the Company in writing of any claim by the Internal Revenue Service that, if successful, would require
the payment by the Company of the Gross-Up Payment. Such notification will be given as soon as practicable but no later than ten business days after Executive is informed in writing of such claim and apprises the Company of the nature of such claim
and the date on which such claim is requested to be paid. The Executive will not pay such claim prior to the expiration of the 30-day period following the date on which it gives such notice to the Company (or such shorter period ending on the date
that any payment of taxes with respect to such claim is due). If the Company notifies Executive in writing prior to the expiration of such period that it desires to contest such claim, Executive will: 
  
 (i) give the Company any information reasonably requested by
the Company relating to such claim, 
  
 (ii) take
such action in connection with contesting such claim as the Company reasonably requests in writing from time to time, including, without limitation, accepting legal representation with respect to such claim by an attorney reasonably selected by the
Company, 
  
 (iii) cooperate with the Company in
good faith in order effectively to contest such claim, and 
  
 (iv) permit the Company to participate in any proceedings relating to such claim; 
  
 provided, however, that the Company will bear and pay directly all costs and expenses (including additional interest and penalties) incurred in connection with such
contest and will indemnify and hold Executive harmless, on an after-tax basis, for any Excise Tax or income tax (including interest and penalties with respect thereto) imposed as a result of such representation and payment of costs and expenses.
Without limitation of the foregoing provisions of this Section 10(c), the Company will control all proceedings 

  

 - 13 - 

 
taken in connection with such contest and, at its sole option, may pursue or forgo any and all administrative appeals, proceedings, hearings and conferences
with the taxing authority in respect of such claim and may, at its sole option, either direct Executive to pay the tax claimed and sue for a refund or contest the claim in any permissible manner, and Executive agrees to prosecute such contest to a
determination before any administrative tribunal, in a court of initial jurisdiction and in one or more appellate courts, as the Company will determine; provided, however, that if the Company directs Executive to pay such claim and sue for a refund,
the Company will advance the amount of such payment to Executive, on an interest-free basis and will indemnify and hold Executive harmless, on an after-tax basis, from any Excise Tax or income tax (including interest or penalties with respect
thereto) imposed with respect to such advance or with respect to any imputed income with respect to such advance; and further provided that any extension of the statute of limitations relating to payment of taxes for the taxable year of Executive
with respect to which such contested amount is claimed to be due is limited solely to such contested amount. Furthermore, the Company’s control of the contest will be limited to issues with respect to which a Gross-Up Payment would be payable
hereunder and Executive will be entitled to settle or contest, as the case may be, any other issue raised by the Internal Revenue Service or any other taxing authority. 
  
 (d) If, after the receipt by Executive of an amount advanced by the Company pursuant to Section 10(c),
Executive becomes entitled to receive any refund with respect to such claim, Executive will (subject to the Company’s complying with the requirements of Section 10(c)) promptly pay to the Company the amount of such refund (together with any
interest paid or credited thereon after taxes applicable thereto). If, after the receipt by Executive of an amount advanced by the Company pursuant to Section 10(c), a determination is made that Executive is not entitled to any refund with respect
to such claim and the Company does not notify Executive in writing of its intent to contest such denial of refund prior to the expiration of 30 days after such determination, then such advance will be forgiven and will not be required to be repaid
and the amount of such advance will offset, to the extent thereof, the amount of Gross-Up Payment required to be paid. 
  
 11. Costs of Enforcement. Unless otherwise provided by the arbitrator(s) in an arbitration proceeding pursuant to Section 14 hereof, in any action
taken in good faith relating to the enforcement of this Agreement or any provision herein, Executive will be entitled to be paid any and all costs and expenses incurred by him in enforcing or establishing his rights thereunder, including, without
limitation, reasonable attorneys’ fees, whether suit be brought or not, and whether or not incurred in trial, bankruptcy or appellate proceedings, but only if Executive is successful on at least one material issue raised in the enforcement
proceeding. 
  
 12. Representations and Warranties. Except
as separately disclosed to the Company in writing prior to the Effective Date, Executive hereby represents and warrants to the Company that Executive is not a party to, or otherwise subject to, any covenant not to compete with any person or entity,
and Executive’s execution of this Agreement and 

  

 - 14 - 

 
performance of his obligations hereunder will not violate the terms or conditions of any contract or obligation, written or oral, between Executive and any
other person or entity. 
  
 13. Restrictions on Conduct of
Executive. 
  
 (a) General. Executive
and the Company understand and agree that the purpose of the provisions of this Section 13 is to protect legitimate business interests of the Company, as more fully described below, and is not intended to eliminate Executive’s post-employment
competition with the Company per se, nor is it intended to impair or infringe upon Executive’s right to work, earn a living, or acquire and possess property from the fruits of his labor. Executive hereby acknowledges that the
post-employment restrictions set forth in this Section 13 are reasonable and that they do not, and will not, unduly impair his ability to earn a living after the termination of this Agreement. Therefore, subject to the limitations of reasonableness
imposed by law, Executive will be subject to the restrictions set forth in this Section 13. 
  
 (b) Definitions. The following terms used in this Section 13 have the meanings assigned to them below, which definitions apply to
both the singular and the plural forms of such terms: 
  
 “Competitive Position” means any employment with a Competitor in which Executive will use or is likely to use any Confidential Information or Trade Secrets, or in which Executive has duties for such Competitor that
relate to Competitive Services and that are the same or similar to those services actually performed by Executive for the Company; 
  
 “Competitive Services” means the provision of health information products and services, including, without
limitation, practice management systems, value-added networks, information management, health management services and health-related e-commerce. 
  
 “Competitor” means any Person engaged, wholly or in part, in Competitive Services, including, but not limited to, as of
the date of this Agreement, Siemens Medical Solutions, McKesson Corporation and its subsidiaries, Verispan, IMS Health Incorporated, PDX and its affiliates, IDX Systems Corporation, WebMD Corporation including Envoy, Cardinal Health and its
subsidiaries, QS1, Ateb Inc, PCS and ArcLight Systems. 
  
 “Confidential Information” means all information regarding the Company, its activities, business or clients that is the subject of reasonable efforts by the Company to maintain its confidentiality and that is not generally
disclosed by practice or authority to persons not employed by the Company, but that does not rise to the level of a Trade Secret. “Confidential Information” includes, but is not limited to, financial plans and data concerning the Company;
management planning information; business plans; operational methods; market studies; marketing plans or strategies; product development 

  

 - 15 - 

 
techniques or plans; lists of current or prospective customers; details of customer contracts; current and anticipated customer requirements; past, current
and planned research and development; business acquisition plans; and new personnel acquisition plans. “Confidential Information” does not include information that has become generally available to the public by the act of one who has the
right to disclose such information without violating any right or privilege of the Company. This definition will not limit any definition of “confidential information” or any equivalent term under state or federal law. 
  
 “Determination Date” means the date of
termination of Executive’s employment with the Company for any reason whatsoever or any earlier date of an alleged breach of the Restrictive Covenants by Executive. 
  
 “Person” means any individual or any corporation, partnership, joint venture, limited
liability company, association or other entity or enterprise. 
  
 “Principal or Representative” means a principal, owner, partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant.

  
 “Protected Customers” means
any Person to whom the Company has sold its products or services or solicited to sell its products or services during the twelve (12) months prior to the Determination Date. 
  
 “Protected Employees” means employees of the Company who were employed by the Company at
any time within six (6) months prior to the Determination Date. 
  
 “Restricted Period” means the Employment Period and a period extending eighteen (18) months from the termination of Executive’s employment with the Company. 
  
 “Restricted Territory” means the state of
Georgia, any other state in which the Company has an office location, and any country outside of the United States in which the Company has an office location. 
  

“Restrictive Covenants” means the restrictive covenants contained in Section 13(c) hereof. 
  
 “Trade Secret” means all information,
without regard to form, including, but not limited to, technical or nontechnical data, a formula, a pattern, a compilation, a program, a device, a method, a technique, a drawing, a process, financial data, financial plans, product plans,
distribution lists or a list of actual or potential customers, advertisers or suppliers which is not commonly known by or available to the public and which information: (A) derives economic value, actual or potential, from not 

  

 - 16 - 

 
being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and
(B) is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. Without limiting the foregoing, Trade Secret means any item of Confidential Information that constitutes a “trade secret(s)” under the
common law or applicable state law. 
  
 (c)
Restrictive Covenants. 
  
 (i)
Restriction on Disclosure and Use of Confidential Information and Trade Secrets. Executive understands and agrees that the Confidential Information and Trade Secrets constitute valuable assets of the Company and its affiliated entities, and
may not be converted to Executive’s own use. Accordingly, Executive hereby agrees that Executive will not, directly or indirectly, at any time during the Restricted Period reveal, divulge, or disclose to any Person not expressly authorized by
the Company any Confidential Information, and Executive will not, directly or indirectly, at any time during the Restricted Period use or make use of any Confidential Information in connection with any business activity other than that of the
Company. Throughout the term of this Agreement and at all times after the date that this Agreement terminates for any reason, Executive will not directly or indirectly transmit or disclose any Trade Secret of the Company to any Person, and will not
make use of any such Trade Secret, directly or indirectly, for himself or for others, without the prior written consent of the Company. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the
Company’s rights or Executive’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. 
  
 Anything herein to the contrary notwithstanding, Executive will not be restricted from disclosing or using Confidential Information that
is required to be disclosed by law, court order or other legal process; provided, however, that in the event disclosure is required by law, Executive will provide the Company with prompt notice of such requirement so that the Company may seek an
appropriate protective order prior to any such required disclosure by Executive. 
  
 (ii) Nonsolicitation of Protected Employees. Executive understands and agrees that the relationship between the Company and each of
its Protected Employees constitutes a valuable asset of the Company and may not be converted to Executive’s own use. Accordingly, Executive hereby agrees that during the Restricted Period Executive will not directly or indirectly on
Executive’s own behalf or as a Principal or Representative of any Person or otherwise solicit or induce any Protected Employee to terminate his or her employment relationship with the Company or to enter into employment with any other Person.

  
 (iii) Restriction on Relationships with
Protected Customers. Executive understands and agrees that the relationship between the Company and each of its Protected Customers constitutes a valuable asset of the Company and may not be converted to Executive’s own use. Accordingly,
Executive hereby agrees that, during the 

  

 - 17 - 

 
Restricted Period, Executive will not, without the prior written consent of the Company, directly or indirectly, on Executive’s own behalf or as a
Principal or Representative of any Person, solicit, divert, take away or attempt to solicit, divert or take away a Protected Customer for the purpose of providing or selling Competitive Services; provided, however, that the prohibition of this
covenant will apply only to Protected Customers with whom Executive had Material Contact on the Company’s behalf during the twelve (12) months immediately preceding the termination of his employment hereunder. For purposes of this Agreement,
Executive had “Material Contact” with a Protected Customer if (a) he had business dealings with the Protected Customer on the Company’s behalf; (b) he was responsible for supervising or coordinating the dealings between the Company
and the Protected Customer; or (c) he obtained Trade Secrets or Confidential Information about the Protected Customer as a result of his association with the Company. 
  
 (iv) Noncompetition with the Company. The parties acknowledge: (A) that Executive’s services
under this Agreement require special expertise and talent in the provision of Competitive Services and that Executive will have substantial contacts with customers, suppliers, advertisers and vendors of the Company; (B) that pursuant to this
Agreement, Executive will be placed in a position of trust and responsibility and he will have access to a substantial amount of Confidential Information and Trade Secrets and that the Company is placing him in such position and giving him access to
such information in reliance upon his agreement not to compete with the Company during the Restricted Period; (C) that due to his management duties, Executive will be the repository of a substantial portion of the goodwill of the Company and would
have an unfair advantage in competing with the Company; (D) that due to Executive’s special experience and talent, the loss of Executive’s services to the Company under this Agreement cannot reasonably or adequately be compensated solely
by damages in an action at law; (E) that Executive is capable of competing with the Company; and (F) that Executive is capable of obtaining gainful, lucrative and desirable employment that does not violate the restrictions contained in this
Agreement. In consideration of the compensation and benefits being paid and to be paid by the Company to Executive hereunder, Executive hereby agrees that, during the Restricted Period, Executive will not, without prior written consent of the
Company, directly or indirectly seek or obtain a Competitive Position in the Restricted Territory with a Competitor; provided, however, that the provisions of this Agreement will not be deemed to prohibit the ownership by Executive of any securities
of the Company or its affiliated entities or not more than five percent (5%) of any class of securities of any corporation having a class of securities registered pursuant to the Securities Exchange Act of 1934, as amended. 
  
 (v) Cooperation. Throughout the term of this
Agreement and at all times after the date that this Agreement terminates for any reason, Executive will not make statements detrimental to the interests of nor engage in any activities detrimental to the Company or its officers, directors,
stockholders, trustees, employees, agents, parent corporations, subsidiaries, affiliates, estates, successors, assigns and attorneys, nor will Executive make any statements about any of the aforementioned parties to the press (including without
limitation any newspaper, magazine, radio station or television station) 

  

 - 18 - 

 
without the prior written consent of the Company. Executive will also cooperate with the Company and its affiliates as a witness in all matters about which
he has knowledge as a result of his position with the Company and its affiliates if the Company requests his testimony. 
  
 (d) Enforcement of Restrictive Covenants. 
  

(i) Rights and Remedies Upon Breach. In the event Executive breaches, or threatens to commit a breach of, any of the provisions
of the Restrictive Covenants, the Company will have the following rights and remedies, which will be independent of any others and severally enforceable, and will be in addition to, and not in lieu of, any other rights and remedies available to the
Company at law or in equity: 
  
 (A) the right
and remedy to enjoin, preliminarily and permanently, Executive from violating or threatening to violate the Restrictive Covenants and to have the Restrictive Covenants specifically enforced by any court of competent jurisdiction, it being agreed
that any breach or threatened breach of the Restrictive Covenants would cause irreparable injury to the Company and that money damages would not provide an adequate remedy to the Company; and 
  
 (B) the right and remedy to require Executive to account
for and pay over to the Company all compensation, profits, monies, accruals, increments or other benefits derived or received by Executive hereunder after his Date of Termination, excluding any Accrued Obligations. 
  
 (ii) Severability of Covenants. Executive
acknowledges and agrees that the Restrictive Covenants are reasonable and valid in time and scope and in all other respects. The covenants set forth in this Agreement will be considered and construed as separate and independent covenants. Should any
part or provision of any covenant be held invalid, void or unenforceable in any court of competent jurisdiction, such invalidity, voidness or unenforceability will not render invalid, void or unenforceable any other part or provision of this
Agreement. If any portion of the foregoing provisions is found to be invalid or unenforceable by a court of competent jurisdiction because its duration, the territory, the definition of activities or the definition of information covered is
considered to be invalid or unreasonable in scope, the invalid or unreasonable term will be redefined, or a new enforceable term provided, such that the intent of the Company and Executive in agreeing to the provisions of this Agreement will not be
impaired and the provision in question will be enforceable to the fullest extent of the applicable laws. 
  

 - 19 - 

 14. Arbitration. Any claim or dispute arising under this Agreement (other than under Section 13)
will be subject to arbitration, and prior to commencing any court action, the parties agree that they will arbitrate all such controversies. The arbitration will be conducted in Atlanta, Georgia, in accordance with the Employment Dispute Rules of
the American Arbitration Association and the Federal Arbitration Act, 9 U.S.C. §1, et. seq. The arbitrator(s) will be authorized to award both liquidated and actual damages, in addition to injunctive relief, but no punitive damages. The
arbitrator(s) may also award attorney’s fees and costs, without regard to any restriction on the amount of such award under Georgia or other applicable law. Such an award will be binding and conclusive upon the parties hereto, subject to 9
U.S.C. §10. Each party will have the right to have the award made the judgment of a court of competent jurisdiction. 
  

			
	 	  	_________
	 	  	Executive
		
	 	  	_________
	 	  	Company

  
 15. Letter of
Credit. In order to ensure the payment of the severance benefit provided for in Section 8(d)(ii) of this Agreement, immediately following the commencement of any action by a third party with the aim of effecting a Change in Control of the
Company, or the publicly-announced threat by a third party to commence any such action, the Company shall establish an irrevocable standby Letter of Credit issued by a national banking association in favor of Executive in the amount of the severance
payment that would have been paid to Executive under Section 8(d)(ii) if the Date of Termination had occurred on the date of commencement, or publicly-announced threat of commencement, of such action by the third party. Such Letter of Credit shall
provide that the issuer thereof, subject only to Executive’s written certification to such issuer that Executive is entitled to payment of the severance benefit pursuant to Section 8(d)(ii) of this Agreement and that the Company shall have
failed to make payment of such benefit to Executive, shall have the unconditional obligation to pay the amount of such Letter of Credit to Executive on the 31st day after the Date of Termination. In the event that subsequent to such payment to
Executive pursuant to such Letter of Credit (i) the Company and Executive shall mutually agree that Executive shall not have been entitled to payment of the severance benefit pursuant to Section 8(d)(ii) of this Agreement or (ii) a court of
competent jurisdiction shall finally adjudge Executive not to have been entitled to payment of such severance benefit and such judgment shall have been affirmed on appeal or shall not have been appealed within any time period specified for the
filing of an appeal, Executive shall promptly pay to the Company the total amount previously paid to Executive by the issuer of such Letter of Credit and no further payment shall be made to Executive pursuant to such Letter of Credit. 
  
 16. Assignment and Successors. 
  
 (a) This Agreement is personal to Executive and without the
prior written consent of the Company will not be assignable by Executive otherwise than by will or the 

  

 - 20 - 

 
laws of descent and distribution. This Agreement will inure to the benefit of and be enforceable by the Executive’s legal representatives. 

 
 (b) This Agreement will inure to the benefit of and be
binding upon the Company and its successors and assigns. 
  
 (c) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” means the Company as hereinbefore
defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. 
  
 17. Miscellaneous. 
  
 (a) Waiver. Failure of either party to insist, in one or more instances, on performance by the other in strict accordance with the
terms and conditions of this Agreement will not be deemed a waiver or relinquishment of any right granted in this Agreement or of the future performance of any such term or condition or of any other term or condition of this Agreement, unless such
waiver is contained in a writing signed by the party making the waiver. 
  
 (b) Severability. If any provision or covenant, or any part thereof, of this Agreement should be held by any court to be invalid, illegal or unenforceable, either in whole or in part, such invalidity,
illegality or unenforceability will not affect the validity, legality or enforceability of the remaining provisions or covenants, or any part thereof, of this Agreement, all of which will remain in full force and effect. 
  
 (c) Other Agents. Nothing in this Agreement is
to be interpreted as limiting the Company from employing other personnel on such terms and conditions as may be satisfactory to it. 
  
 (d) Entire Agreement. Except as provided herein, this Agreement contains the entire agreement between the Company and Executive
with respect to the subject matter hereof and, from and after the Effective Date, this Agreement will supersede any other agreement between the parties with respect to the subject matter hereof. 
  
 (e) Governing Law. Except to the extent preempted by
federal law, and without regard to conflict of laws principles, the laws of the State of Georgia will govern this Agreement in all respects, whether as to its validity, construction, capacity, performance or otherwise. 
  

 - 21 - 

 (f) Notices. All notices, requests, demands and other communications required or
permitted hereunder will be in writing and will be deemed to have been duly given if delivered or three days after mailing if mailed, first class, certified mail, postage prepaid: 
  

			
	To Company:	  	 NDCHealth Corporation
 National Data Plaza

Attention: Walter M. Hoff
 Atlanta, Georgia 30329-2010

		
	To Executive:	  	 Lee Adrean
 744 Conway Glen Drive
 Atlanta, Georgia 30327

  
 Any party may change
the address to which notices, requests, demands and other communications will be delivered or mailed by giving notice thereof to the other party in the same manner provided herein. 
  
 (g) Amendments and Modifications. This Agreement may be amended or modified only by a writing signed
by both parties hereto, which makes specific reference to this Agreement. 
  
 (h) Binding Effect. Except as otherwise provided in this Agreement, every covenant, term and provision of this Agreement will bind and inure to the benefit of each party’s respective successors,
transferees and permitted assigns. 
  
 (i)
Construction. In construing and enforcing this Agreement, the following rules will be followed: 
  
 (i) Each provision of this Agreement will be construed simply according to its fair meaning and not strictly for or against any party. No
consideration will be given to the fact or presumption that any party had a greater or lesser hand in drafting this Agreement. 
  
 (ii) In construing and enforcing this Agreement, no consideration will be given to the captions of the articles, sections, subsections,
and clauses of this Agreement, which are inserted for convenience in organizing and locating the provisions of this Agreement, not as an aid in its construction. 
  
 (iii) Plural words will be understood to include their singular forms, and vice versa. 
  
 (iv) The word “include” and its syntactical forms
mean “include, but are not limited to,” and corresponding syntactical forms. The principal of ejusdem generis will not be used to limit the scope of the category of things illustrated by the items mentioned in a clause introduced by
the word “including.” 
  

 - 22 - 

 (v) A defined term has its defined meaning through this Agreement, regardless of where in
this Agreement the term is defined. 
  
 (vi)
Except as otherwise provided in this Agreement, a reference to an Article, Section, or clause means an article, section, or clause of this Agreement and may be understood to mean, for example, “Section 5.1 of this Agreement” or
“Section 5.1 hereof.” The term “Section” may be used variously to identify entire Sections (as in “Section 6.8”), subsections (as in “Section 6.8(a)”), and clauses (as in “Section 6.8(h)(iii)”).

  
 (j) Incorporation by Reference. The
exhibits to this Agreement are incorporated in this Agreement by reference. 
  
 (k) Time. Time is of the essence in this Agreement. 
  
 (l) Counterparts. This Agreement may be executed in any number of counterparts with the same effect as if all of the parties had
signed the same document. All counterparts will be construed together and will constitute one agreement. 
  
 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Employment Agreement as of the date first above written. 
  

			
	 NDCHEALTH CORPORATION

		
	 By:
	 	/s/  Walter M. Hoff
	 	 	 Walter M. Hoff
 Chief Executive Officer

	
	 EXECUTIVE:

	
	 /s/  Lee Adrean

	 Lee Adrean

  

 - 23 - 

 EXHIBIT A 
 Form of Release 
  
 This
Release is granted effective as of the      day of                     ,
            , by Lee Adrean (“Executive”) in favor of NDCHealth Corporation (the “Company”). This is the Release referred to in that certain Employment Agreement
dated as of May 11, 2004 by and between the Company and Executive (the “Employment Agreement”). Executive gives this Release in consideration of the Company’s promises and covenants as recited in the Employment Agreement, with respect
to which this Release is an integral part. 
  
 1. Release of
the Company. Executive, for himself, his successors, assigns, attorneys, and all those entitled to assert his rights, now and forever hereby releases and discharges the Company and its respective officers, directors, stockholders, trustees,
employees, agents, parent corporations, subsidiaries, affiliates, estates, successors, assigns and attorneys (“the Released Parties”), from any and all claims, actions, causes of action, sums of money due, suits, debts, liens, covenants,
contracts, obligations, costs, expenses, damages, judgments, agreements, promises, demands, claims for attorney’s fees and costs, or liabilities whatsoever, in law or in equity, which Executive ever had or now has against the Released Parties,
including any claims arising by reason of or in any way connected with any employment relationship which existed between the Company or any of its parents, subsidiaries, affiliates, or predecessors, and Executive. It is understood and agreed that
this Release is intended to cover all actions, causes of action, claims or demands for any damage, loss or injury, which may be traced either directly or indirectly to the aforesaid employment relationship, or the termination of that relationship,
that Executive has, had or purports to have, from the beginning of time to the date of this Release, whether known or unknown, that now exists, no matter how remotely they may be related to the aforesaid employment relationship including but not
limited to claims for employment discrimination under federal or state law, except as provided in Paragraph 2; claims arising under Title VII of the Civil Rights Act, 42 U.S.C. § 2000(e), et seq. or the Americans With Disabilities
Act, 42 U.S.C. § 12101 et seq.; claims for statutory or common law wrongful discharge, including any claims arising under the Fair Labor Standards Act, 29 U.S.C. § 201 et seq.; claims for attorney’s fees,
expenses and costs; claims for defamation; claims for wages or vacation pay; claims for benefits, including any claims arising under the Employee Retirement Income Security Act, 29 U.S.C. § 1001, et seq.; and provided, however,
that nothing herein will release the Company of its obligations to Executive under the Employment Agreement or any other contractual obligations between the Company or its affiliates and Executive, or any indemnification obligations to Executive
under the Company’s bylaws, certificate of incorporation, Delaware law or otherwise. 
  
 2. Release of Claims Under Age Discrimination in Employment Act. Without limiting the generality of the foregoing, Executive agrees that by executing this Release, he has released and waived any and all claims
he has or may have as of the date of this Release for age discrimination under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq. It is understood that Executive is advised to consult with an attorney prior to
executing this Release; that he in fact has consulted a knowledgeable, 

  

 
competent attorney regarding this Release; that he may, before executing this Release, consider this Release for a period of twenty-one (21) calendar days;
and that the consideration he receives for this Release is in addition to amounts to which he was already entitled. It is further understood that this Release is not effective until seven (7) calendar days after the execution of this Release and
that Executive may revoke this Release within seven (7) calendar days from the date of execution hereof. 
  
 Executive agrees that he has carefully read this Release and is signing it voluntarily. Executive acknowledges that he has had twenty one (21) days from
receipt of this Release to review it prior to signing or that, if Executive is signing this Release prior to the expiration of such 21-day period, Executive is waiving his right to review the Release for such full 21-day period prior to signing it.
Executive has the right to revoke this release within seven (7) days following the date of its execution by him. However, if Executive revokes this Release within such seven (7) day period, no severance benefit will be payable to him under the
Employment Agreement and he will return to the Company any such payment received prior to that date. 
  
 EXECUTIVE HAS CAREFULLY READ THIS RELEASE AND ACKNOWLEDGES THAT IT CONSTITUTES A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS AGAINST THE COMPANY UNDER
THE AGE DISCRIMINATION IN EMPLOYMENT ACT. EXECUTIVE ACKNOWLEDGES THAT HE HAS HAD A FULL OPPORTUNITY TO CONSULT WITH AN ATTORNEY OR OTHER ADVISOR OF HIS CHOOSING CONCERNING HIS EXECUTION OF THIS RELEASE AND THAT HE IS SIGNING THIS RELEASE VOLUNTARILY
AND WITH THE FULL INTENT OF RELEASING THE COMPANY FROM ALL SUCH CLAIMS. 
  

 - 2 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]